Anteris Technologies Ltd is a structural heart company committed to designing, developing, and commercialising innovative medical devices.
Founded in Australia, with a significant presence in Minneapolis, USA (a MedTech hub), Anteris is science-driven, with an experienced team of multidisciplinary professionals delivering transformative solutions to structural heart disease patients. The company’s lead product, DurAVRTM, is a transcatheter heart valve (THV) for treating aortic stenosis.